Oak Street Health, Inc. (NYSE:OSH – Get Rating) – Equities researchers at SVB Leerink issued their FY2027 earnings per share estimates for Oak Street Health in a report released on Tuesday, January 10th. SVB Leerink analyst W. Mayo forecasts that the company will post earnings of $0.81 per share for the year. SVB Leerink currently has a “Market Perform” rating and a $33.00 target price on the stock. The consensus estimate for Oak Street Health’s current full-year earnings is ($2.26) per share.
Oak Street Health (NYSE:OSH – Get Rating) last released its earnings results on Monday, November 7th. The company reported ($0.56) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.63) by $0.07. The firm had revenue of $545.70 million during the quarter, compared to the consensus estimate of $540.28 million. Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 26.04%.
A number of other equities research analysts also recently weighed in on the company. Morgan Stanley upgraded Oak Street Health from an “equal weight” rating to an “overweight” rating in a research report on Monday, November 14th. Raymond James downgraded Oak Street Health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 21st. UBS Group dropped their price target on Oak Street Health from $28.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 6th. Finally, Canaccord Genuity Group dropped their price target on Oak Street Health from $32.00 to $27.00 in a report on Wednesday, November 9th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $31.07.
Oak Street Health Stock Performance
OSH opened at $28.77 on Wednesday. Oak Street Health has a 1-year low of $13.29 and a 1-year high of $30.89. The business has a 50 day moving average price of $21.06 and a two-hundred day moving average price of $23.42.
Insider Buying and Selling at Oak Street Health
In other Oak Street Health news, COO Brian Clem sold 5,000 shares of the business’s stock in a transaction on Tuesday, November 1st. The shares were sold at an average price of $20.57, for a total transaction of $102,850.00. Following the sale, the chief operating officer now directly owns 556,337 shares of the company’s stock, valued at approximately $11,443,852.09. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold a total of 15,000 shares of company stock valued at $332,100 in the last three months. 11.40% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Oak Street Health
Institutional investors and hedge funds have recently modified their holdings of the stock. Heritage Wealth Management LLC purchased a new position in shares of Oak Street Health during the 2nd quarter valued at $58,000. Captrust Financial Advisors grew its holdings in shares of Oak Street Health by 114.5% during the 1st quarter. Captrust Financial Advisors now owns 2,688 shares of the company’s stock valued at $72,000 after acquiring an additional 1,435 shares in the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Oak Street Health by 1,496.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 3,480 shares of the company’s stock valued at $93,000 after acquiring an additional 3,262 shares in the last quarter. MetLife Investment Management LLC purchased a new position in shares of Oak Street Health during the 1st quarter valued at $159,000. Finally, Wealthspire Advisors LLC purchased a new position in shares of Oak Street Health during the 2nd quarter valued at $164,000. 92.04% of the stock is currently owned by hedge funds and other institutional investors.
Oak Street Health Company Profile
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oak Street Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Oak Street Health wasn’t on the list.
While Oak Street Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
